Skip to main content
Skip to footer

Reinstating the Pharma Supply Chain Post COVID-19 Pandemic Disruptions

Mithugopal Mandal

Senior Management Consultant, Life Sciences Advisory Services, TCS

You have these already downloaded

We have sent you a copy of the report to your email again.

The crisis has triggered the need for approaches that companies can take to circumvent challenges and get their production back on track

Supply chain is the backbone of pharma manufacturing. Global disruptions from COVID-19 pandemic have severely impacted the supply chains. Unless the organizations plan effectively, there is a chance it may take longer to recover than expected. This whitepaper addresses the key areas the organizations need to focus on and take the quick action.

 

About the Author

Mithugopal Mandal
Mithugopal is a Senior Management Consultant in TCS’ Life Science Advisory Practice.

Related reading

Investigating Drug Interaction Under Hypoxia to Treat COVID-19

White Paper | 15 Mar 2023

Leveraging TCS Real World Evidence Services for Tangible Outcomes

Solution | 01 Mar 2023

The Emerging Trends of Microneedles for Insulin Delivery

White Paper | 28 Feb 2023

Metaverse in Healthcare: Realizing Business Value and Opportunities

White Paper | 18 Jan 2023

Transformation starts here

Integrated ecosystems are key to better patient outcomes.

Talk to our experts

Find out more